Joshua D. Robinson

Mahmoud E. Khani, Ethan M. I. Johnson, Aparna Sodhi et al.

In this paper, we explored the use of deep learning for the prediction of aortic flow metrics obtained using 4D flow MRI using wearable seismocardiography (SCG) devices. 4D flow MRI provides a comprehensive assessment of cardiovascular hemodynamics, but it is costly and time-consuming. We hypothesized that deep learning could be used to identify pathological changes in blood flow, such as elevated peak systolic velocity Vmax in patients with heart valve diseases, from SCG signals. We also investigated the ability of this deep learning technique to differentiate between patients diagnosed with aortic valve stenosis (AS), non-AS patients with a bicuspid aortic valve (BAV), non-AS patients with a mechanical aortic valve (MAV), and healthy subjects with a normal tricuspid aortic valve (TAV). In a study of 77 subjects who underwent same-day 4D flow MRI and SCG, we found that the Vmax values obtained using deep learning and SCGs were in good agreement with those obtained by 4D flow MRI. Additionally, subjects with TAV, BAV, MAV, and AS could be classified with ROC-AUC values of 92%, 95%, 81%, and 83%, respectively. This suggests that SCG obtained using low-cost wearable electronics may be used as a supplement to 4D flow MRI exams or as a screening tool for aortic valve disease.

Tina Yao, Nicole St. Clair, Gabriel F. Miller et al.

Purpose: To develop and evaluate an end-to-end deep learning pipeline for segmentation and analysis of cardiac magnetic resonance images to provide core-lab processing for a multi-centre registry of Fontan patients. Materials and Methods: This retrospective study used training (n = 175), validation (n = 25) and testing (n = 50) cardiac magnetic resonance image exams collected from 13 institutions in the UK, US and Canada. The data was used to train and evaluate a pipeline containing three deep-learning models. The pipeline's performance was assessed on the Dice and IoU score between the automated and reference standard manual segmentation. Cardiac function values were calculated from both the automated and manual segmentation and evaluated using Bland-Altman analysis and paired t-tests. The overall pipeline was further evaluated qualitatively on 475 unseen patient exams. Results: For the 50 testing dataset, the pipeline achieved a median Dice score of 0.91 (0.89-0.94) for end-diastolic volume, 0.86 (0.82-0.89) for end-systolic volume, and 0.74 (0.70-0.77) for myocardial mass. The deep learning-derived end-diastolic volume, end-systolic volume, myocardial mass, stroke volume and ejection fraction had no statistical difference compared to the same values derived from manual segmentation with p values all greater than 0.05. For the 475 unseen patient exams, the pipeline achieved 68% adequate segmentation in both systole and diastole, 26% needed minor adjustments in either systole or diastole, 5% needed major adjustments, and the cropping model only failed in 0.4%. Conclusion: Deep learning pipeline can provide standardised 'core-lab' segmentation for Fontan patients. This pipeline can now be applied to the >4500 cardiac magnetic resonance exams currently in the FORCE registry as well as any new patients that are recruited.